Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day: Patients w/ #amyloidosis & implanted cardioverter defibrillators (mean follow-up of 4.9 yrs) have high rates of mortality w/ similar outcomes for AL & ATTR, and also high rates of inappropriate shocks for both AL and TTR.”
Title: Characteristics and outcomes of implantable cardioverter defibrillator therapy in patients with cardiac amyloidosis
Authors: Robert Seby, Azalfa Lateef, Krista Grennan, Kiyan Heybati, Jessica Laenger, Yaohua Ma, Kevin Tayon, Awais Malik, Melissa Lyle, Freddy Del-Carpio Munoz, S. Michael Gharacholou
You can read the full article on BMC Cardiovascular Disorders.
You can find other articles featuring Robert Orlowski on OncoDaily.
